Involvement of catalase in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells
Viability assay
DOI:
10.1016/j.cbi.2011.06.009
Publication Date:
2011-07-06T04:46:54Z
AUTHORS (10)
ABSTRACT
Apigenin has been reported to inhibit proliferation of cancer cells; however, the mechanism underlying its action is not completely understood. Here, we evaluated effects apigenin on levels expression and activity antioxidant enzymes, involvement ROS in cell death induced by HepG2 human hepatoma cells. Upon treatment with apigenin, cells displayed a reduction viability dose- time-dependent manner, some morphological changes. In addition, generation significantly decreased mRNA catalase intracellular GSH. On other hand, did alter or enzymes. Addition exogenous reduced death. We also demonstrated that are more sensitive apigenin-mediated than primary cultures mouse hepatocytes, suggesting differential toxic effect this agent tumor Our results suggest apigenin-induced apoptosis may be mediated H(2)O(2)-dependent pathway via defenses.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (69)
CITATIONS (56)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....